IMMUTEP LTD Chart calendar Immutep Ltd
48e45296b57.agslsan-xVtqNS-jXxNBgpVFRfrOdxcAq026waLdMqE.CEFL3NOSgzJSckvtDFcV06EEKs6cL2R49GCIq5SMWOcuOlPZ5a_9PCtWdg~27d6b6a71628083e6e32218406a8ef53
Upcoming events on Immutep Ltd
Past events on Immutep Ltd
| 2024-07-11 07:00 pm | TACTI-003 Phase IIb Results Call |
| 2024-07-11 07:00 pm | ESMO Virtual Plenary Session |
| 2024-07-11 12:30 pm | ESMO Virtual Plenary Session - Oral Presentation |
| 2024-06-26 07:00 pm | TACTI-003 Phase IIb Trial Call |
| 2024-06-04 | Rights Issue: 1 new share @ 0.38 AUD for 16 existing shares |
| 2024-05-30 | American Society of Clinical Oncology Meeting |
| 2024-05-28 | Bell Potter Emerging Leaders Conference |
| 2024-05-14 | European Society for Medical Oncology Meeting |
| 2024-04-28 06:18 pm | March 2024 Sales and Revenue Release - Activities Report |
| 2024-02-27 05:39 pm | Q2 2024 Earnings Release |
| 2024-02-15 08:30 pm | ShareCafe Hidden Gems Webinar |
| 2024-02-05 11:40 pm | Euroz Hartleys Healthcare Forum |
| 2024-01-29 04:32 pm | December 2023 Sales and Revenue Release - Activities Report |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-11-15 10:00 am | Jefferies London Healthcare Conference |
| 2023-11-13 | Immuno-Oncology Europe Conference |
| 2023-11-09 10:30 am | Baird Biotech Discovery Series |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 595 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 595 |
| 2023-10-31 | AusBiotech Conference |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 7,49 0,00 - | 16,5 13,0 26.47% | 0,00 4,95 - | 6,76 4,04 67.13% | 5,20 6,15 -15.41% | 3,11 |
|
EBITDA Million AUD | Released Forecast Spread | -18,3 -7,55 -142.58% | 0,00 0,00 - | -17,6 -19,1 7.93% | -30,1 -35,5 15.3% | -37,8 -41,3 8.49% | -45,8 |
|
EBIT Million AUD | Released Forecast Spread | -20,2 -15,0 -34.9% | -12,3 -15,6 20.94% | -19,7 -24,1 18.34% | -32,1 -36,9 12.9% | -39,9 -44,2 9.86% | -48,0 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -18,3 -18,5 0.96% | -13,5 -15,4 12.69% | -29,9 -30,8 2.83% | -32,2 -36,8 12.45% | -39,9 -43,4 8.08% | -47,6 |
|
Net income Million AUD | Released Forecast Spread | -18,3 -12,8 -43.47% | -13,5 -15,4 12.47% | -29,9 -30,8 2.83% | -32,2 -36,8 12.45% | -39,9 -43,4 8.08% | -46,9 |
|
EPS AUD | Released Forecast Spread | -0,06 -0,03 -90% | -0,03 0,00 -1020% | -0,05 -0,04 -13.93% | -0,04 -0,04 12.63% | -0,04 -0,04 -3% | -0,04 |
| Announcement Date | 20/08/19 | 25/08/20 | 30/08/21 | 31/08/22 | 29/08/23 | - |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 0,00 - | 0,00 1,08 - | 2,08 1,40 48.57% | 3,91 3,20 22.07% | 2,62 3,23 -19.05% | 4,11 2,10 95.73% | 1,20 | |||
|
EBITDA Million AUD | Released Forecast Spread | -9,34 -9,40 0.62% | -8,24 -9,70 15% | -15,0 -15,1 0.99% | -15,7 -16,2 3.21% | -19,7 | -21,8 | -23,8 | -23,6 | ||
|
EBIT Million AUD | Released Forecast Spread | -5,37 -5,10 -5.37% | -6,94 -9,52 27.09% | -10,4 -12,3 15.38% | -9,26 -13,5 31.62% | -16,8 -15,1 -11.65% | -15,9 -17,9 11.42% | -20,6 -19,0 -8.69% | -19,3 -22,6 14.77% | -21,2 -23,9 11.13% | -25,4 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -5,95 -5,10 -16.69% | -7,52 -9,57 21.42% | -19,8 -14,1 -41.17% | -10,1 -15,3 34.43% | -16,3 -15,1 -8.1% | -15,9 -18,0 11.44% | -20,6 -19,2 -7.18% | -19,3 -21,2 9.06% | -21,2 -23,7 10.48% | -26,1 |
|
Net income Million AUD | Released Forecast Spread | -5,95 -5,10 -16.7% | -7,52 -9,52 21% | -19,8 -14,1 -41.17% | -10,1 -15,3 34.43% | -16,3 -15,1 -8.1% | -15,9 -18,1 11.69% | -20,6 -12,8 -60.78% | -19,3 -21,9 11.98% | -21,2 -23,7 10.48% | -24,5 |
|
EPS AUD | Released Forecast Spread | -0,04 -0,04 4.25% | -0,01 -0,03 52% | -0,02 -0,02 0% | -0,02 -0,02 15.91% | -0,02 -0,02 -2.61% | -0,02 -0,02 14.76% | -0,02 | |||
| Announcement Date | 20/02/20 | 25/08/20 | 23/02/21 | 30/08/21 | 24/02/23 | 31/08/22 | 24/02/23 | 29/08/23 | 27/02/24 | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 2024-07-22 07:00 am | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Immutep Ltd
| 2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
